Sign in
4

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0001171843-26-007547

Chief Accounting Officer bought 10,000 shares at $0.59 ($5,900)

From the SEC's structured data for this filing

Trades in this filing

Lerner Neil · Chief Accounting Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-11-17 Purchase : show line 1 in the form +10,000 $0.59 $5,900 430,000 D
Open-market purchases · 10,000 sh · avg $0.59 · $5,900
Loading xslF345X06/ownership.xml…